Two Sigma Investments’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-104,290
| Closed | -$117K | – | 3774 |
|
|
2025
Q2 | $117K | Sell |
104,290
-35,480
| -25% | -$43.3K | ﹤0.01% | 2984 |
|
|
2025
Q1 | $161K | Buy |
139,770
+32,150
| +30% | +$59.8K | ﹤0.01% | 2897 |
|
|
2024
Q4 | $658K | Buy |
107,620
+71,343
| +197% | +$848K | ﹤0.01% | 2402 |
|
|
2024
Q3 | $600K | Sell |
36,277
-14,070
| -28% | -$154K | ﹤0.01% | 2379 |
|
|
2024
Q2 | $346K | Buy |
50,347
+33,012
| +190% | +$282K | ﹤0.01% | 2530 |
|
|
2024
Q1 | $167K | Buy |
+17,335
| New | +$201K | ﹤0.01% | 2753 |
|
|
2023
Q2 | – | Sell |
-11,400
| Closed | -$157K | – | 3129 |
|
|
2023
Q1 | $157K | Buy |
+11,400
| New | +$236K | ﹤0.01% | 2607 |
|
|
2022
Q4 | – | Sell |
-9,281
| Closed | -$211K | – | 2923 |
|
|
2022
Q3 | $211K | Buy |
+9,281
| New | +$187K | ﹤0.01% | 2088 |
|
|
2022
Q2 | – | Sell |
-18,057
| Closed | -$483K | – | 2708 |
|
|
2022
Q1 | $483K | Sell |
18,057
-55,825
| -76% | -$1.04M | ﹤0.01% | 2031 |
|
|
2021
Q4 | $2.17M | Buy |
73,882
+64,438
| +682% | +$3.2M | ﹤0.01% | 1849 |
|
|
2021
Q3 | $621K | Buy |
9,444
+4,444
| +89% | +$340K | ﹤0.01% | 3058 |
|
|
2021
Q2 | $416K | Buy |
+5,000
| New | +$370K | ﹤0.01% | 3248 |
|
Other funds holding IGMS
Two Sigma Investments's IGMS Position: Q3 2025 in Review
Two Sigma Investments sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 104,290 shares — an estimated $117K sold.
Two Sigma Investments first reported a position in IGMS in Q2 2021 and held it in 12 quarters. The position peaked at $2.17M in Q4 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Two Sigma Investments reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Two Sigma Investments sold 104,290 IGM Biosciences shares in Q3 2025, an estimated $117K.
- Two Sigma Investments first reported a position in IGM Biosciences in Q2 2021 and held it in 12 quarters.
- Two Sigma Investments's IGM Biosciences position peaked at $2.17M in Q4 2021.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.